ERBB2 and triple-negative breast carcinoma: Accordingly, siRNA-mediated knockdown of DUSP6 reduced HER2 and HER3 protein levels in MDA-MB-453, HCC1954, and the HER3+ triple-negative breast cancer cell line MDA-MB-468 (Fig. 6H; Appendix Fig. S5D,E).